Determination of retroviral mutation rates using spleen necrosis virus-based vectors and helper cells.
Dougherty
J P
JP
Temin
H M
HM
D000818:Animals; D001482:Base Composition; D001483:Base Sequence; D002934:Cinnamates; D004285:Dogs; D004351:Drug Resistance; D015870:Gene Expression; D005814:Genes, Viral; D005822:Genetic Vectors; D005839:Gentamicins / Q000494:pharmacology; D006921:Hygromycin B / Q000031:analogs & derivatives / Q000494:pharmacology; D008969:Molecular Sequence Data; D009154:Mutation; D012516:Osteosarcoma; D016133:Polymerase Chain Reaction; D011533:Proviruses / Q000235:genetics* / Q000502:physiology; D015183:Restriction Mapping; D012190:Retroviridae / Q000235:genetics* / Q000502:physiology; D014162:Transfection; D014407:Tumor Cells, Cultured; D014779:Virus Replication
D002934:Cinnamates; D005839:Gentamicins; D006921:Hygromycin B; C026273:hygromycin A; C010680:antibiotic G 418